Deventer, November 22, 2024 – 819 Capital Partners has acquired and invested in CiMaas, a biotech company dedicated to developing Natural Killer cell therapy to improve cancer treatment and patient outcomes.

Deventer, November 22, 2024 – 819 Capital Partners has acquired and invested in CiMaas, a biotech company dedicated to developing Natural Killer cell therapy to improve cancer treatment and patient outcomes.

Deventer, November 19, 2024 – 819 Capital Partners and LIOF have invested in I-Med Technology (“I-Med”) in a substantial investment round. I-Med Technology develops and markets advanced head-mounted 3D imaging systems that provide real-time support, enhancing precision and efficiency in medical and dental procedures.

Deventer, October 3, 2024 – 819 Capital Partners has acquired Travelhome, the Dutch market leader in global motorhome travel. Together with general director Perry van de Wiel, we have acquired Travelhome from ANWB through a management buy-out.

819 Capital Partners has recently invested in Vidiia Ltd. from 819 Evergreen Fund, alongside a bio-scientist entrepreneur, the University of Surrey and Brunel University London.

Deventer, June 13, 2024 – 819 Capital Partners has acquired the Touroperating division from ANWB through a buy-out, together with the management team Gert-Jan Bressers and Richard Broekhoven. The new organization will continue under the name Fox Reizen and will continue to develop and execute member trips for the ANWB.

819 Capital Partners is pleased to share that we recently became a member of the Nederlandse Vereniging van Participatiemaatschappijen (NVP), the Dutch Association for Private Equity and Venture Capital!

LipoCoat Holdings (“LipoCoat”), a portfolio company from 819 Capital Partners, strategically acquired Sono-Coat. The deal is backed by a growth investment directly into Sono-Coat BV (“Sono-Coat”) led by 819 Capital Partners (“819”) from their 819 Evergreen Fund.

819 Capital Partners (819) has acquired Direct Diagnostics from Sanquin Health Solutions (SHS). The acquisition is accompanied by an additional growth investment from 819.

Golden Egg Check has announced that their venture capital fund GEC Capital has raised 2.5 million euros. 819 Capital Partners is one of the new cornerstone investors in the fund.
